ERT Does Not Increase Breast Cancer Recurrence or Mortality. From: Family Practice News | Date: May 15, 1999| Author: | COPYRIGHT 1999 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group.Copyright information

WHITE SULPHUR SPRINGS, W.VA. -- Women with a history of breast cancer who were on estrogen replacement therapy had a lower incidence of cancer recurrence and a lower mortality rate, compared with those who were not on ERT in a study of 76 patients.

"Physicians should not automatically discourage [breast cancer survivors] from taking ERT," study investigator Dr. Puthugraman Natrajan reported at the annual meeting of the South Atlantic Association of Obstetricians and Gynecologists.

The survival rate was 94% for patients who were taking ERT, 87% for none-strogen hormone ...